Insulet (PODD) FY2019 results: revenue $738 million, up 30.9% on the year
Insulet Corp. (PODD) reported revenue of $738 million for fiscal 2019, the year ended 31 December 2019, up 30.9% on the year before. Net income was $12 million, up 251.5%, and diluted earnings per share $0.19. The figures are the company's own, from the 10-K it filed with the SEC on 26 February 2020.
Revenue
$738 million
+30.9% on the year
FY2012FY2019
Operating margin
6.8%
4.9% a year earlier
FY2012FY2019
Net income
$12 million
+251.5% on the year
FY2012FY2019
Diluted EPS
$0.19
+280.0% on the year
FY2012FY2019
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Revenue
738
564
464
+30.9%
Cost of revenue
258
194
187
+33.2%
Gross profit
480
370
277
+29.8%
Gross margin
65.1%
65.7%
59.8%
Research and development
132
94.8
75.7
+39.6%
Selling, general and administrative
298
248
n/a
+20.2%
Operating income
50.0
27.4
-7.4
+82.3%
Operating margin
6.8%
4.9%
-1.6%
Interest expense
34.6
28.9
21.2
+19.7%
Pre-tax income
14.5
5.2
-26.6
+178.8%
Income tax
2.9
1.9
0.2
+52.6%
Effective tax rate
20.0%
36.5%
n/a
Net income
11.6
3.3
-26.8
+251.5%
Net margin
1.6%
0.6%
-5.8%
Diluted EPS
$0.19
$0.05
-$0.46
+280.0%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Operating cash flow
98.4
35.9
41.3
+174.1%
Capital expenditure
164
157
73.8
+4.0%
Free cash flow
-65.3
-122
-32.5
Free cash flow margin
-8.8%
-21.5%
-7.0%
Cash from investing
-73.6
-185
-211
Cash from financing
73.5
-8.7
305
Depreciation and amortisation
27.9
15.6
13.9
+78.8%
Share-based compensation
28.7
37.5
31.9
-23.5%
Diluted shares, weighted
62m
61m
58m
+2.1%
Shares outstanding at period end
63m
59m
58m
+5.9%
Balance sheet
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Shareholders' equity
75.9
212
159
-64.2%
Debt
888
592
566
+50.0%
Operating lease liabilities
14.4
n/a
n/a
Other liabilities
165
125
92.1
+32.1%
Total liabilities and equity
1,143
929
817
+23.1%
Fixed assets
399
258
108
+54.6%
Goodwill
39.8
39.6
39.8
+0.4%
Intangible assets
13.2
10.4
4.4
+27.1%
Investments
221
316
293
-30.1%
Cash and equivalents
214
114
273
+87.6%
Receivables
69.3
63.3
53.4
+9.5%
Inventory
101
71.4
33.8
+41.4%
Other assets
85.7
55.9
11.9
+53.3%
Total assets
1,143
929
817
+23.1%
10-K for the year ended 31 December 2019, filed 26 February 2020: the filing.